QualityStocks News Alert
  The QualityStocks Daily Newsletter for Tuesday March 3rd, 2009 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


Shell Stock Review (FREZ)


Knobias Clip Report (RVDO)


Wall Street Resources (GSAC)

The QualityStocks Daily

Lighting Science Group Corporation (LSCG)

Knobias and OTC Picks reported previously on Lighting Science Group Corporation (LSCG), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Lighting Science Group Corporation designs and sells highly energy efficient and environmentally friendly lighting solutions. They base these solutions on their proprietary Optimized Digital Lighting® (ODL®) technology. These solutions are for consumer and professional applications. With headquarters in Dallas, Texas, the company also has offices in New York, New York; Westampton, New Jersey; Sacramento, California; Satellite Beach, Florida; Tokyo, Japan; Goes, The Netherlands; Buckinghamshire, England; and Sydney, Australia.

Lighting Science Group designs and manufactures ready to use LED lamps and luminiares. Lighting Science engages in customized product development for Original equipment manufacturers (OEMs) who want to bring a new product to market, or enter new markets. They design and develop a wide range of custom lighting systems, including digital light engines for existing solutions, to complete new solutions by leveraging the unique characteristics of LEDs. They have supplied OEM components for gaming, architectural lighting, consumer products, and other industries and applications.

The Company's patented and patent pending designs in power management, thermal management, light engines, controls, microelectronics, manufacturing processes, and other areas seek to reduce energy consumption. They also engineer these to enhance lighting performance, lower maintenance costs, and eliminate the use of hazardous materials. They do this while delivering environmental benefits to users.

In addition, they offer customized lighting solutions for architectural and artistic projects. Their Custom Architectural Solutions consider the needs of their customer, the context of the project location, and then add the creativity of their designers. They design using their advanced tools and technology in the context of consistent, unified aesthetic and structural principles. The Company then proceeds to refine, amplify, and improve in consultation with their clients and designers. They manufacture a product to the precise specifications required by the project application. This is all within the parameters identified during the design process.

Lighting Science Group Corporation (LSCG) closed Tuesday's session at $0.85 up $0.20 or 30.77 percent. Volume was 208,345 for a 3-month average volume of 15,492.20.

Nayarit Gold Inc. (NYG.V)

Investor Relations reported recently on Nayarit Gold Inc. (NYG.V) and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Nayarit Gold Inc. is a Canadian gold and silver exploration company. With headquarters in Nova Scotia , Canada , the Company trades on the TSX Venture Exchange. Formed in May of 2005, their corporate strategy is to build Nayarit Gold Inc. into a profitable resource company through exploration of their high quality mining properties in the State of Nayarit , Mexico . They control over 102,000 hectares of mining concessions, known as the Orion Project, in this Mexican state.

The Orion Project is Nayarit's flagship project. This project lies in the Sierra Madre Occidental, which is a prolific mining district in northern Mexico . The project consists of a series of old high-grade silver and gold mines. These mines all exist in an east-west vein system. The Company's early results at the Orion site show that a significant rich vein system occurs in the northern portion of the Orion Project, where drilling has been concentrating. These types of mineral systems can extend for up to 1000 meters in depth.

Nayarit Gold Inc. announced in the fall of 2008 that Mr. Hall Stewart joined Nayarit as a technical consultant. He assumed the role of Vice President of Exploration in October of last year. Mr. Stewart has over twenty years of experience in exploration and resource development, and an impressive record of accomplishment of discovery in Mexico . Mr. Stewart was involved in discoveries totaling 6.98 million gold-equivalent ounces at the Magistral, Ocampo, and Palmarejo projects in Mexico between 1995 and 2006.

Nayarit Gold has their 30,000-meter Phase II drill program at the Orion District. They continued step out drilling last fall, east of their discovery zone and encountered a broad section of high-grade gold and silver mineralization. They evaluated data received from step out drilling on Sections 1079 and 1159.

On February 10, 2009, Nayarit Gold announced an additional intersection of 8.7 Meters of 11.7 g/t Gold, and 1,304 g/t Silver, or 33.4 g/t Gold Equivalent, or 2,006 g/t Silver Equivalent.

This is from their Phase II drill program at the Orion District in the State of Nayarit . They are completing a series of infill and expansion holes at their Animas/Del Norte Discovery zone. The Company's plan is to complete a NI 43-101 resource estimate by the end of the second quarter of 2009.

The Animas/Del Norte Discovery is within the northern portion of the Orion Concession. The Discovery consists of a series of three parallel veins. Animas and Del Norte are the dominant two. They discovered this deposit in August 2007 when they drilled a series of holes under historic workings along the veins. They have since continued to drill out the limits of the system.

Today, Nayarit Gold Inc. (NYG.V) closed trading at $0.59, which was up $0.04 or 7.27 percent. Volume was 114,490 for a 3-month average volume of 147,838.

Raptor Pharmaceuticals Corp. (RPTP)

Clip Report reported recently on Raptor Pharmaceuticals Corp. (RPTP), Knobias did earlier, and today we highlight the Company as "One to Watch", here at the QualityStocks Daily Newsletter.

Raptor Pharmaceuticals Corp. is a development-stage biotechnology company with their corporate headquarters in Novato , California . They engage in the acquisition, development, and commercialization of pharmaceutical products in the United States . As an OTCBB-traded enterprise, they dedicate their efforts to speeding the delivery of new treatment options to patients. They do this by working to improve existing therapeutics through the application of highly specialized drug targeting platforms and formulation expertise.

The Company focuses on underserved patient populations. Their DR Cysteamine is an investigational, delayed-release (DR) oral formulation of cysteamine bitartrate. This is for the potential treatment of nephropathic cystinosis (cystinosis), which is a rare lysosomal storage disease. Raptor's DR Cysteamine formulation may require less frequent dosing and reduce gastrointestinal side effects.

The company is also developing DR Cysteamine for the potential treatment of Non-alcoholic Steatohepatitis (NASH), Huntington's Disease, and Batten Disease. Additionally, Raptor is in clinical development of Convivia™ for the potential treatment of aldehyde dehydrogenase (ALDH2) deficiency.

Raptor Pharmaceuticals Corp. bases their preclinical programs on bioengineered novel drug candidates and drug-targeting platforms derived from the human receptor-associated protein (RAP) and related proteins. The design of these is to target cancer, neurodegenerative disorders, and infectious diseases. Their preclinical programs include HepTide™, WntTide™ and NeuroTrans™.

Last month, Raptor Pharmaceuticals announced the completion of patient enrollment in their Phase 2a open-label clinical trial to evaluate cysteamine bitartrate (cysteamine) in patients diagnosed with non-alcoholic steatohepatitis (NASH). NASH patients currently can only manage their disease through weight control, diet, and exercise. NASH is a progressive form of liver disease and is one of the leading causes of cirrhosis in the U.S. It accounts for approximately 10 percent of newly diagnosed cases of chronic liver disease.

Ted Daley, President of Raptor's clinical division stated, "Raptor's strategy is to leverage cysteamine's known safety profile for the treatment of cystinosis and potential efficacy in several other indications. In this case, cysteamine represents an exciting potential treatment for NASH, a disease that may have a severe impact on the long-term health of a growing worldwide patient population among both adults and adolescents."

We are tracking Raptor Pharmaceuticals Corp. (RPTP) on our radar screens as "One to Watch", here at the QualityStocks Daily Newsletter.

Today, Raptor Pharmaceuticals Corp. (RPTP) closed at $0.22 down $0.08 or 26.67 percent. Volume was 1,200 for a 3-month average volume of 48,213.10.

Wellstar International Inc. (WLSI)

Today, HotOTC.com and Cool Penny Stocks reported on Wellstar International Inc. (WLSI), Willy Wizard, OTC Reporter did recently, Standout Stocks did earlier, and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Wellstar International, Inc., through their wholly owned operating subsidiary Trillenium Medical Imaging, Inc. (TMI), is working to become a leading diagnostic company in the health care industry. Headquartered in Holland, Ohio, TMI developed and is marketing fully- calibrated and functional thermal imaging systems. The systems utilize state-of-the-art infrared technologies and proprietary software to measure physiological changes in the human body, accurately and cost-effectively.

Infrared thermal imaging is a non-invasive imaging procedure. It involves the detection and recording of skin thermal patterns, providing visual and quantitative documentation. Infrared Imaging can display the variations in skin temperature patterns and these variations, known pathways of information, can be an integral part of a physical examination.

This technology is currently in use to assist in diagnosis, treatment monitoring and case management of many health issues.  These include, among others, vascular, neurological, and muscular-skeletal disorders such as breast cancer, diabetes, and unresolved pain issues related to myofascial complaints, muscle injury or neurological dysfunction.

Trillennium Medial Imaging, Inc., through parent Wellstar International, has partnered with Mikron Infrared. TMI Infrared Systems incorporate only Class-A thermal detectors supplied by Mikron Infrared for the highest quality and consistency in temperature measurement. Mikron Infrared is a leader in the supply and manufacture of Infrared devices. Trillennium Medical Imaging, through their alliance with MIKRON/NEC, offers worldwide sales and distribution. Local distributors are in most of the continental U.S.A, and Canada , Mexico , South America, and the Middle East .

Yesterday, Wellstar International, Inc. announced that their wholly owned subsidiary, Trillenium Medical Imaging (TMI), would utilize Wellstar Medical Advisory Board Members Dr. Courtney Lyder and Edna Atwater to assist with the rollout of their thermal imaging systems to long-term care (LTC) facilities nationwide.

Dr. Courtney Lyder has a background in wound care, hospital operations, and nurse care management. This expertise will play a significant role in expanding the Company's client base among the LTC facilities. Edna Edwards Atwater has been a registered nurse in North Carolina since 1975. Since 1998, Atwater has held several key positions at Duke University Medical Center , including administrator and Director for the Wound Management Institute.

Wellstar's CEO, John Antonio, stated, "I look forward to working with Courtney and Edna in the coming months. Their leadership and experience will certainly provide the Company with an advantage as we start the roll-out of our thermal imaging systems to the LTC facilities."

Wellstar International Inc. (WLSI) closed today's session at $0.0034 up $0.0013 or 61.90 percent. Volume was 82,330,303.

BioTime Inc. (BTIM)

HotOTC.com reported recently, Stock Egg, Standout Stocks, The Street Alert, SmallCap Voice, Clip Report, MicroCap Press did earlier, and today we highlight BioTime Inc. (BTIM), here at the QualityStocks Daily Newsletter.

BioTime Inc. develops blood plasma volume expanders, blood replacement solutions for hypothermic (low temperature) surgery, organ preservation solutions, and technology for use in surgery, emergency trauma treatment, and other applications. The Company trades on the OTCBB and has their headquarters in Alameda , California . The Company is part of the Biotechnology industry in the Healthcare sector.

The Company's lead product is Hextend. In the United States, Hospira, Inc. manufactures and distributes this lead product. In South Korea, CJ CheilJedang Corp. manufactures and distributes Hextend. In both countries the performance of these activities are under exclusive licensing agreements.

BioTime's products are for medical applications including the treatment of hypovolemia caused by surgical blood loss, the emergency treatment of blood loss due to traumatic injury, and the preservation of body organs and tissues awaiting transplant. They are also for the replacement of all of a patient's circulating blood during cardiac surgery and neurosurgery that involve lowering the patient's body temperature to hypothermic levels, as well as other biomedical applications.

The Company's solutions are synthetic and sterilization of them can take place under high temperatures and pressures. In addition, they do not pose a risk of transmitting infectious agents. BioTime also operates in the field of regenerative medicine through their wholly owned subsidiary Embryome Sciences, Inc. They develop new medical and research products using embryonic stem cell technology through this subsidiary.

In 2008, BioTime and the International Longevity Center-USA announced a collaboration focusing on research, education, and advocacy for regenerative medicine and its application in aging. The International Longevity Center is a non-profit international research, policy, and education organization. They formed to educate individuals on how to live longer and better, and advise society on how to maximize the benefits of technology, such as the emerging field of regenerative medicine for today's age boom.

Last Thursday, BioTime announced that their wholly owned subsidiary Embryome Sciences, Inc. entered into an agreement with Reproductive Genetics Institute (RGI) of Chicago , Illinois . This agreement grants Embryome Sciences rights to market new human embryonic stem cell (hES) lines selected by Embryome Sciences from 294 hES lines derived by RGI. BioTime's strategy is for Embryome Sciences to become a leader in the field of regenerative medicine by bringing some of the most advanced stem cell technologies to the market in the near-term as research products.

Today, BioTime Inc. (BTIM) closed at $1.75 up $0.29 or 19.86 percent. Volume was 123,468 for a 3-month average volume of 93,072.10.

BWI Holdings Inc. (BWIH)

Today, XplosiveStocks.com, StockEgg.com, ShazamStocks.com, OTC Picks, Inside Move, and HotOTC.com reported on BWI Holdings Inc. (BWIH), OTC Stock Review did earlier, and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

BWI Holdings Inc., doing business as Budget Waste Inc., is a waste solutions company in Western Canada. They provide complete waste and recycling services. Incorporated on Aug. 10, 2006 as Gray Creek Mining Inc., the Company changed their name to BWI Holdings, Inc. on Nov. 7, 2008. Subsequently, on November 10, 2008, they acquired 100 percent of the outstanding shares of Budget Waste Inc., an Alberta , Canada corporation, from Budget Waste, Inc. a Nevada corporation. They trade on the OTCBB and have their corporate headquarters in Calgary , Alberta , Canada .

BWI provides their services to commercial, industrial, construction, home building, oilfield, and residential clients. BWI Holdings, Inc. provides non-hazardous waste collection, transfer, recycling and disposal services. They also provide support to the construction industry. This includes fence rentals, sanitary facility rentals, bin rentals, hydrovac and water hauling. BWI Holdings operates mainly, although not exclusively, in Alberta . BWI Holdings Inc. operates in the solid waste, liquid services, water hauling, and septic services business segments.

BWI Holdings garners their collection revenue from services provided to commercial and residential customers. They typically perform services to commercial customers under service agreements or pursuant to contracts with municipalities. They charge fees based on collection frequency, level of service, route density, and the type, volume and weight of the waste collected. They also base their fees on type of equipment and containers furnished, the distance to the disposal, the cost of disposal, and prices charged by competitors for similar services.

Today, Jim Can, CEO of BWI Holdings, Inc. announced the Town of Chestermere has renewed their curbside contract for another five years commencing March 1, 2009. BWI will provide weekly curbside refuse pickup to approximately 5,000 homes. The revenue generated from this agreement is approximately $500,000 per year or 2.5 million over five years.

BWI Holdings Inc. (BWIH) closed today's session at $0.76 up $0.09 or 13.43 percent. Volume was 230,331. The 3-month average volume is 20,882.

eMagin Corporation (EMAN)

SmallCap Voice reported earlier on eMagin Corporation (EMAN), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Founded in 1996, eMagin Corporation is a leader in organic light-emitting diode (OLED) microdisplays and virtual imaging technology. Trading on the OTCBB, their microdisplay manufacturing and research and development operations are with IBM on their campus in East Fishkill, New York . Their system design facilities, sales, and marketing offices are in Bellevue , Washington .

eMagin Corporation integrates high-resolution OLED microdisplays with magnifying optics. They do this to deliver virtual images comparable to large-screen computer and television displays in portable, low-power, lightweight personal displays. eMagin microdisplays provide near-eye imagery for a vibrant user experience. These microdisplays are for military, industrial, medical, and consumer original equipment manufacturers products.

eMagin's Z800 3DVisor provides 3D stereovision and head tracking for PC gaming, training and simulation, immersion therapy, and other applications. The Z800 3DVisor delivers a quality gaming experience. It is power efficient, and the Company based it on their OLED microdisplays and patented optics. The Z800 3DVisor delivers high-color, high-contrast imagery equivalent to a 105-inch screen viewed at twelve feet, in full-color stereovision. The high-speed head tracking enables 360-degree viewing. It has an integrated audio system with high-fidelity ear buds and a built-in noise-canceling microphone.

eMagin's scientists and engineers have developed the technology and expertise to apply emissive materials to silicon-based chips to make very high performance, high-resolution microdisplays. Sophisticated lightweight optics and efficient drive circuitry are required to make these displays into near eye systems.

The Company's designs combine lightness, power-efficiency, durability, wide viewing angle, and comfortable viewing, and include monocular and stereo viewing systems. eMagin's virtual imaging systems bring the clarity of an HDTV screen or computer monitor to near-eye systems. They find use in jet pilot's command headsets to firefighters' smoke-penetrating vision systems to portable DVD viewing screens.

Today, eMagin Corporation announced their participation at the upcoming 20th Annual Financial Analyst Conference sponsored by The Wall Street Analysts Forum. Andrew Sculley, eMagin's Chief Executive Officer, is scheduled to make a presentation at 11:50 a.m. Eastern Time on Thursday, March 26, 2009, at the University Club in New York.

Today, eMagin Corporation (EMAN) closed trading at $0.39 up $0.04 or 11.43 percent. Volume was 32,288 for a 3-month average volume of 26,514.80.

Impax Laboratories Inc. (IPXL)

Clip Report reported recently, Knobias did previously, and today we highlight Impax Laboratories Inc. (IPXL), here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, Impax Laboratories Inc. is a technology based specialty pharmaceutical company. They are applying their formulation expertise and drug delivery technology to the development of controlled-release and specialty generics. They are also applying this expertise to the development of branded products. The Company has their headquarters in Hayward , California as well as an office in Philadelphia , Pennsylvania .

Impax Laboratories markets their generic products via their Global Pharmaceuticals division. In addition, they market their branded products through the Impax Pharmaceuticals division. Impax also develops marketing partnerships, when feasible, to fully leverage their technology platform.

In the generic pharmaceuticals market, the Company mainly focuses on selected controlled-release generic versions of brand name pharmaceuticals.  Impax Laboratories is also developing other generic pharmaceuticals that they believe present one or more competitive barriers to entry. These include difficulty sourcing raw materials, complex formulation or development characteristics, or special handling requirements.

The Company is developing products for the treatment of central nervous system (CNS) disorders. This is in the brand name pharmaceuticals market.  Their initial brand name product portfolio consists of development–stage projects. They are developing differentiated, modified, or controlled-release versions of currently marketed drug substances.  The Company plans to expand their brand name products portfolio mainly through internal development and through licensing and acquisition.

On February 5, 2009, Impax Laboratories, Inc. confirmed that the U.S. Food and Drug Administration (FDA) granted final approval of the Company's Abbreviated New Drug Application (ANDA) for generic versions of SOLODYN® (minocycline HCI) 45mg, 90mg, and 135mg Extended-release Tablets. Medicis markets SOLODYN® for the treatment of moderate-to-severe acne.

Today, Impax announced that Arthur A. Koch, Jr., would present at the Barclays Global Healthcare Conference on Tuesday, March 10, at 3:15 p.m. Eastern time. The conference will take place at the Lowes Miami Beach Hotel, Florida from March 10 to 11, 2009. Arthur A. Koch, Jr. is the Senior Vice President and Chief Financial Officer of Impax Laboratories Inc.

Impax Laboratories Inc. (IPXL) closed today's session at $5.80 down $0.15 or 2.52 percent. Volume was 288,224 for a 3-month average volume of 52,787.50.

The QualityStocks Company Corner

Sector 10 Inc. (SECT)
Superlattice Power Inc. (SLAT)

AM Oil Resources & Tech.(AMOR)
Axial Vector Energy Corp. (AXVC)

Sector 10 Inc. (SECT)

The QualityStocks Daily Newsletter would like to spotlight Sector 10 Inc. (SECT) Today, Sector 10 Inc. closed trading at $0.034, for no change from yesterday's close. Their volume today was 122,291 shares for a 3-month average volume of 31,054.70 shares.

Today, Sector 10, Inc. held an interactive media investor conference to discuss the uses and benefits of the PLX-3D software.

Sector 10 Inc. is focused on becoming the world's leading provider of mobile and stationary emergency life response equipment. The company dedicates its efforts to restructuring a fragmented industry with its globally patented Mobile and Stationary Response Unit (”MRU” and “SRU”) product lines and saving lives.

While expanding its global client base, Sector 10 strives to remain rooted in its core competencies and operating principles. The company's strategy is to continue to invest in management and business development, increase efficiency, manage risk and further strengthen our culture. Sector 10 aims to reach corporate profitability and produce a favorable investment environment by establishing a balanced trend of growth and capital management.

The company is perfectly positioned to capitalize on an extremely fragmented industry and dominate its future growth. While billions of tax dollars are wasted in emergency response, little is spent on preparedness. Through Sector 10's pre-deployed solutions, immediate help and safety is available to those who need it most. These systems provide first aid supplies, life saving equipment, occupant tracking through a real-time 3D interface, and emergency communications.

Leading the way at Sector 10 is Pericles DeAvila who serves as the company's CEO, inventor and lead creative thinker. DeAvila is responsible for all strategic, financial and operational aspects of Sector 10 and its associated businesses. DeAvila studied business and construction management in California and also studied at the Institute University of the Azores. He fluently speaks Portuguese, Italian, French, Spanish, as well as English and has entrepreneurial experience nationally and internationally. Disclaimer

Superlattice Power Inc. (SLAT)

The QualityStocks Daily Newsletter would like to spotlight Superlattice Power Inc. (SLAT). Today, Superlattice Power Inc. closed trading at $0.235, which was up $0.035 or 17.50 percent. Their volume today was 27,000 shares for a 3-month average volume of 18,826.20 shares.

Superlattice Power, Inc. is focused on using its resources and efforts to develop and market lithium-powered vehicles and products for use in residential and commercial properties. Using its technology, the company is able to covert scooters, bicycles, mopeds, motorcycles, cars and even homes and businesses into zero-emission, lithium-powered vehicles and facilities.

The company has made considerable progress in advancing its next generation lithium-powered batteries. It is currently developing a new cathode material that can be integrated into a Lithium-ion polymer battery to substantially increase operating voltage range as well as energy density. With the new cathode material, electric vehicles will be able to travel over 200 miles versus the current 120-140 range.

Superlattice Power, Inc. recently announced that its new cathode material can now enter large-scale production. This technological breakthrough will give Superlattice Power the ability to produce all the necessary physical materials at a batch of 100kg each, making it more practical and affordable for the public to switch from gasoline-powered vehicles to emissions-free vehicles powered by Supperlattice's unique technology.

As prices for fossil fuel energy continue to rise, consumers and businesses are seeking an alternative way to power their world. Scientists, analysts and automotive executives have agreed that rising fuel costs and environmental concerns will cause the sales of hybrid and electric vehicles to skyrocket, and Superlattice has positioned itself to take advantage of the anticipated demand. Disclaimer

Superlattice Power, Inc. Daily Blog

Superlattice Power Inc. News:

Major US Company Set to Achieve Advanced Development of Lithium Ion Battery Technology Using Superlattice's Partially Lithiated Cathode and Anode

Superlattice Power Inc. Attracts Major U.S. Company for Development of Lithium Ion Battery Technology Using Its Partially Lithiated Cathode and Anode

Superlattice Power, Inc. (OTCBB:SLAT) Files Patent for Proprietary Chemical Process to Produce New High Purity Nano Cathode Materials in Industrial Scale for Use in Electric Vehicles

AM Oil Resources & Technology, Inc. (AMOR)

The QualityStocks Daily Newsletter would like to spotlight AM Oil Resources & Technology, Inc. (AMOR) Today AM Oil Resources & Technology, Inc. closed trading at $0.27, which was up $0.02 or 8.00 percent. Their volume today was 261,750 shares. Their 3-month average volume is 32,402.60 shares.

AM Oil Resources & Technology Inc. is focused on becoming the premier provider of environmentally friendly thermal extraction technologies for the oil field in both domestic and international markets. The company's fully patented technology has been proven to be highly effective in harvesting a greater amount of oil from marginally producing “stripper wells.”

The average daily production of the 480,000+ stripper wells existing in the U.S. today is less than 2.1 barrels. Once the production of these wells falls below a profitable level, operators can either shut-in the wells, abandon the wells and cease production, or continue to produce at a loss. However, according to the U.S. Department of Energy, stripper wells have yielded, on average, only 20% of the total amount of oil in the reserve. Unless a secondary oil recovery method is used, the remaining 80% stays in the ground unusable forever.

Through the utilization of the Company's innovative recovery technologies, it is possible to recover over 50% of the oil remaining at increased production efficiencies. The management team believes that applying the company's proprietary technologies to marginal wells, with known reserves, will earn a profitable niche in the U.S. petroleum industry. AM Oil is ideally positioned to profit from rising global demand for oil by providing an environmentally safe and cost-effective method of maximizing oil production from existing wells. Disclaimer

AM Oil Resources & Technology, Inc. Daily Blog

AM Oil Resources & Technology, Inc. News:

AM Oil Resources & Technology Appoints Keith Johnson as New CEO

AM Oil Resources & Technology Outlines Goal for 2009


Axial Vector Energy Corporation (AXVC)

The QualityStocks Daily Newsletter would like to spotlight Axial Vector Energy Corp. (AXVC). Today, Axial Vector Energy Corp. closed trading at $0.065, which was down $0.004 or 5.80 percent. Their volume today was 121,911 shares. Their 3-month average volume is 116,974.

Axial Vector Energy Corporation (AXVC) a publicly traded, development-stage company providing global energy solutions, develops multi-fuel engines and generators for use primarily in military and commercial applications.

Founded in 2002, with headquarters in Portland, Oregon, Axial Vector - through a joint venture agreement with Adaptive Propulsion Systems, LLC - develops and manufactures their engines and generators with an eye toward environmental responsibility and social benefit.

Axial Vector Energy Corporation owns, develops and licenses a technologically advanced suite of internal combustion engines and electric power generation modules. The company has also developed the world's only “coreless” no iron electric motors, which consume one half the electricity of conventional electric motors.

These cutting-edge technologies are focused on fulfilling global engine and energy needs by delivering greater fuel-efficiency, cost effectiveness, versatility, and environmental sensitivity than ever before in venues from the commercial to the industrial, including the vehicular and military sectors. Disclaimer

Axial Vector Energy Corporation Blog

Axial Vector Energy Corporation News:

Axial Vector Updates Investment Community

Axial Vector Energy Corp. Summarizes Highlights of Investor Conference Call

Axial Vector Energy Corporation Announces Investor Conference Call Hosted by Company President/CEO, Sanjai Chhaunker



Daily Video
Get the latest market news every weekday at 11am EST with QualityStocks.net anchors Cathy Rankin, Vanessa Ramirez and Jenn Hoffman.

Sponsors of the Day


The QualityStocks Public Company Sponsor News

Superlattice Power, Inc (SLAT)
Major US Company Set to Achieve Advanced Development of Lithium Ion Battery Technology Using Superlattice's Partially Lithiated Cathode and Anode


QualityStocks By The Numbers Report




About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-308-0703